EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MarvelD3 regulates the radiosensitivity of Esophageal squamous cell carcinoma via the MYB/IFI6 axis

Xi Wang, Jinming Cao, Kaixiao Zhou, Yangyang Ge, Wei Zhu, Qi Zhang, Yang Jiao, Jianping Cao

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2025.112282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Xi Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, China; State Key Laboratory of Radiation Medicine …. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Radiation Tolerance, Proto-Oncogene Proteins c-myb. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Soochow University, National Natural Science Foundation of China, Nantong Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tight junction proteins have been implicated in the progression of various diseases. MarvelD3, a member of the MARVEL domain protein family involved in tight junction formation, exhibits diverse expression patterns and functions across different tissues. However, its specific role in esophageal squamous cell carcinoma (ESCC) remains to be elucidated. This study demonstrated that MarvelD3 is significantly overexpressed in ESCC tissues. Furthermore, the knockdown of MarvelD3 enhances the radiosensitivity of ESCC in both in vitro and in vivo models. RNA-sequencing analysis identified Interferon alpha inducible protein 6 (IFI6) as a target of MarvelD3. Co-immunoprecipitation assays revealed an interactive regulatory relationship between MarvelD3 and MYB. Additionally, dual-luciferase reporter gene assays and chromatin immunoprecipitation assays confirmed that MYB directly binds to the promoter of the IFI6 gene, thereby regulating IFI6 transcription. Collectively, these findings suggest that MarvelD3 plays a critical role in modulating the radiosensitivity of ESCC via the MYB/IFI6 axis, uncovering a promising mechanism underlying the pathogenesis and progression of ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaRadiation ToleranceProto-Oncogene Proteins c-mybMembrane ProteinsHumansCell Line, TumorAnimalsGene Expression Regulation, NeoplasticMicePromoter Regions, GeneticMice, Nude

Stichwörter der Autor:innen

ESCCIFI6MYBMarvelD3Radiation

Substanzen

Proto-Oncogene Proteins c-mybMYB protein, humanMembrane Proteins

Autor:innen und Institutionen

  • School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, China; State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China; State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China.
  • School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, China.
  • Radiation Oncology, The Affiliated Tumor Hospital of Nantong University, Nantong 226361, China.
  • School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, China; State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China. Electronic a…

Förderung

  • Soochow University
  • National Natural Science Foundation of China
  • Nantong Municipal Science and Technology Bureau
  • National Health Commission of the People's Republic of China
  • State Key Laboratory of Radiation Medicine and Protection
  • National Key Research and Development Program of China
  • Graduate Research and Innovation Projects of Jiangsu Province
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Wang, X., Cao, J., Zhou, K., Ge, Y., Zhu, W., Zhang, Q., Jiao, Y., & Cao, J. (2026). MarvelD3 regulates the radiosensitivity of Esophageal squamous cell carcinoma via the MYB/IFI6 axis. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112282

Vancouver

Wang X, Cao J, Zhou K, Ge Y, Zhu W, Zhang Q, et al. MarvelD3 regulates the radiosensitivity of Esophageal squamous cell carcinoma via the MYB/IFI6 axis. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112282

BibTeX
@article{Wang2026,
  author = {Wang, Xi and Cao, Jinming and Zhou, Kaixiao and Ge, Yangyang and Zhu, Wei and Zhang, Qi and Jiao, Yang and Cao, Jianping},
  title = {MarvelD3 regulates the radiosensitivity of Esophageal squamous cell carcinoma via the MYB/IFI6 axis},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2025.112282}
}
Kostenlos starten →